Utah Medical Products Inc...

NASDAQ: UTMD · Real-Time Price · USD
55.93
-0.94 (-1.65%)
At close: Aug 15, 2025, 12:28 PM

Utah Medical Products Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
38.83M 39.27M 40.9M 44.08M 46.58M 49.04M 50.22M 51.47M 51.92M 52.48M 52.28M 51.62M 51.24M 50.41M 49.05M 48.15M 46.06M 42.24M
Cost of Revenue
17.11M 16.87M 17.27M 19.54M 20.48M 20.95M 21.05M 20.2M 19.82M 19.97M 20.08M 19.64M 19.37M 18.91M 18.14M 18.08M 17.56M 16.58M
Gross Profit
21.72M 22.41M 23.64M 24.54M 26.1M 28.09M 29.17M 31.27M 32.1M 32.51M 32.2M 31.98M 31.87M 31.5M 30.92M 30.07M 28.49M 25.66M
Operating Income
12.62M 12.86M 13.59M 14.61M 15.23M 16.22M 16.78M 17.9M 19.07M 19.71M 19.79M 19.85M 19.81M 19.51M 18.88M 18.03M 16.52M 13.73M
Interest Income
n/a n/a 915K 915K 915K 915K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
15.49M 15.86M 16.8M 18.2M 18.81M 19.77M 20.09M 20.66M 21.22M 21.25M 20.66M 20.25M 20.07M 19.69M 19.06M 18.17M 16.6M 13.75M
Net Income
12.55M 12.96M 13.87M 15.26M 15.63M 16.38M 16.64M 16.9M 17.25M 17.15M 16.47M 16.05M 15.97M 15.3M 14.79M 14.07M 12.79M 10.68M
Selling & General & Admin
7.63M 8.47M 7.6M 9.22M 10.18M 10.8M 10.7M 10.83M 10.51M 10.29M 11.91M 11.62M 11.54M 11.47M 11.51M 11.54M 11.48M 11.45M
Research & Development
583K 703K 814K 839K 805K 683K 561K 538K 512K 514K 493K 511K 526K 519K 526K 496K 494K 482K
Other Expenses
337K 337K 1.09M 751K 751K -2.56M -1.32M -1.32M -1.32M 2M 8K 8K 8K 8K 10K 10K 11K 11K
Operating Expenses
9.1M 10.05M 10.55M 11.31M 5.46M -667K -146K -43K 6.39M 12.8M 12.41M 12.13M 12.06M 11.99M 12.04M 12.04M 11.97M 11.93M
Interest Expense
n/a n/a n/a 1.76M 1.76M 1.76M 1.76M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
505K 1.05M 1.46M 2.64M 3.06M 2.51M 2.49M 2.31M 1.89M 1.89M 1.51M 1.41M 1.41M 1.41M 1.41M 1.55M 1.55M 1.55M
Cost & Expenses
13.09M 13.29M 27.31M 29.47M 24.56M 26.04M 26.67M 26.78M 32.84M 32.77M 32.49M 31.77M 31.43M 30.9M 30.17M 30.12M 29.54M 28.51M
Income Tax Expense
2.93M 2.9M 2.93M 2.95M 3.18M 3.39M 3.45M 3.76M 3.97M 4.1M 4.19M 4.2M 4.09M 4.39M 4.27M 4.1M 3.8M 3.07M
Shares Outstanding (Basic)
3.31M 3.31M 3.39M 3.48M 3.62M 3.62M 3.63M 3.63M 3.63M 3.63M 3.63M 3.63M 3.64M 3.65M 3.65M 3.65M 3.65M 3.64M
Shares Outstanding (Diluted)
3.25M 3.31M 3.39M 3.48M 3.53M 3.62M 3.63M 3.64M 3.64M 3.64M 3.63M 3.63M 3.65M 3.67M 3.67M 3.66M 3.65M 3.65M
EPS (Basic)
3.72 3.75 3.92 4.24 4.30 4.51 4.58 4.66 4.76 4.73 4.54 4.41 4.38 4.19 4.05 3.86 3.52 2.94
EPS (Diluted)
3.74 3.78 3.95 4.27 4.33 4.50 4.57 4.64 4.74 4.71 4.51 4.39 4.36 4.18 4.05 3.85 3.50 2.92
EBITDA
15.8M 15.35M 17.52M 18.52M 20.19M 22.26M 23.55M 25.39M 26.52M 27.15M 26.87M 26.95M 27M 26.77M 26.16M 25.34M 23.8M 20.95M
EBIT
14.29M 13.89M 14.66M 15.35M 15.98M 16.96M 17.19M 18.31M 19.48M 20.12M 19.79M 19.85M 19.81M 19.52M 18.88M 18.04M 16.53M 13.74M
Depreciation & Amortization
1.5M 1.45M 2.83M 3.14M 4.2M 5.29M 6.37M 7.08M 7.04M 7.04M 7.08M 7.1M 7.19M 7.26M 7.28M 7.32M 7.29M 7.23M